S'abonner

Sampling of melanocytic nevi for research purposes: A prospective, pilot study to determine effect on diagnosis - 24/04/13

Doi : 10.1016/j.jaad.2008.07.020 
Scott R. Florell, MD a, b, , Bruce R. Smoller, MD d, Kenneth M. Boucher, PhD c, Douglas Grossman, MD, PhD a, b, c, Ronald M. Harris, MD, MBA a, b, Glen M. Bowen, MD a, b, Sancy A. Leachman, MD, PhD a, b
a The Melanoma Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 
b Department of Dermatology, University of Utah, Salt Lake City, Utah 
c Department of Oncological Sciences, University of Utah, Salt Lake City, Utah 
d Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 

Reprint requests: Scott R. Florell, MD, Department of Dermatology, University of Utah Health Sciences Center, 4B454 SOM, Salt Lake City, UT 84132.

Abstract

Background

Research on melanocytic nevi predominantly utilizes formalin-fixed, paraffin-embedded tissue, largely limiting research to morphologic and immunohistochemical observations. Withholding portions of fresh nevus tissue for molecular studies could result in the loss of important diagnostic material.

Objective

This study prospectively evaluated melanocytic nevi for histologic homogeneity to determine if using a portion for research would have affected diagnosis.

Methods

Thirty-three subjects were enrolled in a prospective study in which pigmented lesions were chosen for biopsy on a clinical basis. Lesions were sectioned and each piece submitted in a separate block (mean, 2.7; range 2-5 blocks per lesion). Slides from nevi were examined in two phases. In phase I, sections of nevi were randomized and a diagnosis was rendered for each section of nevus. In phase II, the dermatopathologist reviewed all slides for each nevus as a case, similar to the original interpretation of the lesion provided to the clinician. Diagnoses from phases I and II were compared with the original diagnosis.

Results

Case material included 51 melanocytic lesions from 31 subjects. The phase I diagnosis matched the original diagnosis for 99 of 121 slides that showed a melanocytic lesion (82%). The phase II diagnosis matched the original diagnosis for 45 of 51 specimens (88%).

Limitations

The study was limited by: a small number of specimens; the clinician could have chosen clinically homogeneous nevi for biopsy; effect of interobserver and intraobserver variability on diagnosis.

Conclusions

For the majority of melanocytic nevi in this study, the diagnostic information present in one section of a melanocytic nevus could be extrapolated to the remainder of the specimen without adverse consequences from a diagnostic or therapeutic perspective.

Le texte complet de cet article est disponible en PDF.

Plan


 Supported by grants from The Skin Cancer Foundation (to S. R. F.), the Dermatology Foundation Leaders Society Dermatologist Investigator Research Fellowship and Clinical Career Development Award (to S. R. F.); National Institutes of Health grants K23 RR17525-01 (to S. R. F.) and R01 AR50102 (to D. G.), Doris Duke Charitable Foundation (to S. A. L.), Fellowship-To-Faculty Transition Award from the University of Utah funded in part by the Howard Hughes Medical Institute (to S. A. L.), The Huntsman Cancer Foundation (to S. A. L., D. G.), the Tom C. Mathews Jr. Familial Melanoma Research Endowment, Huntsman General Clinical Research Center Public Health Service grant (MO1 RR00064), National Cancer Institute (NCI) Cancer Center Support grants 5P30CA420-14, and the Utah Cancer Registry, funded by Contract # N01-PC-35141 from the NCI with additional support from the Utah Department of Health and the University of Utah.
 Conflicts of interest: None declared.


© 2008  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 59 - N° 5

P. 814-821 - novembre 2008 Retour au numéro
Article précédent Article précédent
  • Unifocality of extramammary Paget disease
  • Ali Hendi, Galen Perdikis, John L. Snow
| Article suivant Article suivant
  • The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease
  • Cynthia M. Magro, Molly E. Dyrsen

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.